Variant report

Variant	nsv1054973
Chromosome Location	chr12:296179-464439
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1632)
CpG islands
(count:3484)
Chromatin interactive
region (count:59)
LncRNA
region (count:16)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1632 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:345774-345842	HepG2	liver:	n/a	n/a
2	ARID3A	chr12:346692-346907	HepG2	liver:	n/a	n/a
3	ARID3A	chr12:319277-319842	HepG2	liver:	n/a	n/a
4	ARID3A	chr12:298349-298388	K562	blood:	n/a	n/a
5	ATF1	chr12:373538-373815	K562	blood:	n/a	n/a
6	ATF1	chr12:308947-309267	K562	blood:	n/a	n/a
7	ATF2	chr12:320931-321290	H1-hESC	embryonic stem cell:	n/a	n/a
8	ATF3	chr12:329110-329313	K562	blood:	n/a	n/a
9	BACH1	chr12:328963-329532	H1-hESC	embryonic stem cell:	n/a	n/a
10	BACH1	chr12:321015-321189	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr12:312656-312881	H1-hESC	embryonic stem cell:	n/a	n/a
12	BACH1	chr12:308502-308715	H1-hESC	embryonic stem cell:	n/a	n/a
13	BATF	chr12:382502-382775	GM12878	blood:	n/a	n/a
14	BCL11A	chr12:368058-368307	GM12878	blood:	n/a	n/a
15	BCL3	chr12:377133-378098	A549	lung:	n/a	n/a
16	BHLHE40	chr12:302513-302839	K562	blood:	n/a	chr12:302670-302679 chr12:302671-302680 chr12:302748-302764 chr12:302671-302680 chr12:302665-302686
17	BHLHE40	chr12:344171-344359	K562	blood:	n/a	chr12:344223-344232 chr12:344217-344238 chr12:344223-344232 chr12:344222-344231 chr12:344221-344234
18	BHLHE40	chr12:319461-319850	HepG2	liver:	n/a	n/a
19	BHLHE40	chr12:366144-366293	K562	blood:	n/a	n/a
20	BHLHE40	chr12:346383-346899	HepG2	liver:	n/a	n/a
21	BHLHE40	chr12:329121-329447	K562	blood:	n/a	n/a
22	BHLHE40	chr12:319181-319880	HepG2	liver:	n/a	n/a
23	BHLHE40	chr12:298253-298607	HepG2	liver:	n/a	n/a
24	BHLHE40	chr12:298401-298467	K562	blood:	n/a	n/a
25	BHLHE40	chr12:319496-319845	HepG2	liver:	n/a	n/a
26	BRCA1	chr12:319500-319950	HepG2	liver:	n/a	n/a
27	BRCA1	chr12:388853-388959	Hela-S3	cervix:	n/a	n/a
28	BRCA1	chr12:298216-298256	HepG2	liver:	n/a	n/a
29	CBX3	chr12:344865-345227	K562	blood:	n/a	n/a
30	CCNT2	chr12:298259-298565	K562	blood:	n/a	n/a
31	CEBPB	chr12:430788-431260	ECC-1	luminal epithelium:	n/a	chr12:430999-431010
32	CEBPB	chr12:430744-431232	ECC-1	luminal epithelium:	n/a	chr12:430999-431010
33	CEBPB	chr12:402424-402682	K562	blood:	n/a	n/a
34	CEBPB	chr12:430833-431166	K562	blood:	n/a	chr12:430999-431010
35	CEBPB	chr12:464261-464523	HepG2	liver:	n/a	n/a
36	CEBPB	chr12:402430-402705	H1-hESC	embryonic stem cell:	n/a	n/a
37	CEBPB	chr12:402387-402742	HepG2	liver:	n/a	n/a
38	CEBPB	chr12:400603-400855	A549	lung:	n/a	chr12:400672-400683
39	CEBPB	chr12:430821-431182	HepG2	liver:	n/a	chr12:430999-431010
40	CEBPB	chr12:430737-431267	MCF-7	breast:	n/a	chr12:430999-431010
41	CEBPB	chr12:402418-402703	A549	lung:	n/a	n/a
42	CEBPB	chr12:400521-400792	HepG2	liver:	n/a	chr12:400672-400683
43	CEBPB	chr12:323305-323515	H1-hESC	embryonic stem cell:	n/a	n/a
44	CEBPB	chr12:430827-431161	IMR90	lung:	n/a	chr12:430999-431010
45	CEBPB	chr12:417631-418127	MCF-7	breast:	n/a	n/a
46	CEBPB	chr12:402384-402731	K562	blood:	n/a	n/a
47	CEBPB	chr12:430816-431188	A549	lung:	n/a	chr12:430999-431010
48	CEBPB	chr12:346655-346961	HepG2	liver:	n/a	n/a
49	CEBPB	chr12:430799-431225	MCF-7	breast:	n/a	chr12:430999-431010
50	CEBPB	chr12:445633-446055	IMR90	lung:	n/a	n/a

(count:3484 , 50 per page) page: 1 2 3 4 5 6 7 ... 70

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:324682-324732	PrEC	prostate:	n/a
2	chr12:322250-322300	SK-N-SH_RA	brain:	n/a
3	chr12:298484-298534	H1-hESC	embryonic stem cell:	embryo
4	chr12:297831-297881	HepG2	liver:	n/a
5	chr12:392537-392587	SKMC	muscle:	n/a
6	chr12:300298-300348	Jurkat	blood:	n/a
7	chr12:296473-296523	SKMC	muscle:	n/a
8	chr12:324682-324732	PrEC	prostate:	n/a
9	chr12:322250-322300	SK-N-SH_RA	brain:	n/a
10	chr12:298484-298534	H1-hESC	embryonic stem cell:	embryo
11	chr12:297831-297881	HepG2	liver:	n/a
12	chr12:392537-392587	SKMC	muscle:	n/a
13	chr12:300298-300348	Jurkat	blood:	n/a
14	chr12:296473-296523	SKMC	muscle:	n/a
15	chr12:296540-296590	HCPEpiC	choroid plexus:	n/a
16	chr12:296609-296659	U87	brain:	n/a
17	chr12:322972-323022	GM12878	blood:	n/a
18	chr12:322659-322709	HAEpiC	amniotic membrane:	n/a
19	chr12:308821-308871	Jurkat	blood:	n/a
20	chr12:316456-316506	K562	blood:	n/a
21	chr12:322888-322938	AG09319	gingival:	n/a
22	chr12:311647-311697	AG09319	gingival:	n/a
23	chr12:323242-323292	SAEC	small airway:	n/a
24	chr12:322641-322691	PrEC	prostate:	n/a
25	chr12:322972-323022	ECC-1	luminal epithelium:	n/a
26	chr12:322649-322699	GM06990	blood:	n/a
27	chr12:334268-334318	MCF10A-Er-Src	breast:	n/a
28	chr12:298268-298318	PANC-1	pancreas:	n/a
29	chr12:323801-323851	IMR90	lung:	fetal
30	chr12:372790-372840	H1-hESC	embryonic stem cell:	embryo
31	chr12:351299-351349	GM12878	blood:	n/a
32	chr12:313104-313154	AG10803	skin:	n/a
33	chr12:322876-322926	HCPEpiC	choroid plexus:	n/a
34	chr12:328227-328277	Jurkat	blood:	n/a
35	chr12:301498-301548	HEEpiC	esophagus:	n/a
36	chr12:372191-372241	AG10803	skin:	n/a
37	chr12:322876-322926	HPAEpiC	pulmonary alveolar:	n/a
38	chr12:324682-324732	NH-A	brain:	n/a
39	chr12:372246-372296	HNPCEpiC	eye:	n/a
40	chr12:324682-324732	PANC-1	pancreas:	n/a
41	chr12:372191-372241	HIPEpiC	eye:	n/a
42	chr12:323392-323442	MCF-7	breast:	n/a
43	chr12:334129-334179	HRPEpiC	eye:	n/a
44	chr12:298484-298534	AG10803	skin:	n/a
45	chr12:322587-322637	HEK293	kidney:	embryo
46	chr12:392537-392587	Hepatocyte	liver:	n/a
47	chr12:324747-324797	GM06990	blood:	n/a
48	chr12:313104-313154	AG04450	lung:	fetal
49	chr12:371916-371966	AG04449	skin:	fetal
50	chr12:316456-316506	NH-A	brain:	n/a

(count:59 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr12:423846..425522-chr12:432470..434859,2	K562	blood:
2	chr12:329421..332739-chr12:333658..336710,3	K562	blood:
3	chr12:381899..385111-chr12:386819..388918,3	K562	blood:
4	chr12:303209..305233-chr12:388816..390804,2	K562	blood:
5	chr12:378409..380462-chr12:383368..386178,2	MCF-7	breast:
6	chr12:424975..427047-chr12:431144..433406,2	MCF-7	breast:
7	chr12:301002..302613-chr12:305489..307990,2	MCF-7	breast:
8	chr12:284226..286607-chr12:303579..306228,2	K562	blood:
9	chr12:311759..314778-chr12:317325..320101,3	MCF-7	breast:
10	chr12:309101..311206-chr12:317148..318705,2	K562	blood:
11	chr12:311562..313775-chr12:316272..318932,2	K562	blood:
12	chr12:371815..374343-chr12:375834..377592,4	K562	blood:
13	chr12:309101..311206-chr12:317148..318705,2	K562	blood:
14	chr12:402335..404067-chr12:405685..407593,2	K562	blood:
15	chr12:378409..380462-chr12:383368..386178,2	MCF-7	breast:
16	chr12:297600..300406-chr12:301639..304265,3	K562	blood:
17	chr12:308043..310053-chr12:310352..312706,2	MCF-7	breast:
18	chr12:261934..262973-chr12:328743..329813,6	MCF-7	breast:
19	chr12:313171..315687-chr12:321794..324554,2	K562	blood:
20	chr12:391396..393092-chr12:395064..396850,2	K562	blood:
21	chr12:438334..440331-chr12:440530..443524,2	MCF-7	breast:
22	chr12:381899..384416-chr12:386819..388918,2	K562	blood:
23	chr12:441029..443655-chr12:446223..448425,2	MCF-7	breast:
24	chr12:371815..373339-chr12:375834..377443,2	K562	blood:
25	chr12:296668..298848-chr12:310032..311975,2	K562	blood:
26	chr12:381899..384416-chr12:386819..388918,2	K562	blood:
27	chr12:381899..385111-chr12:386819..388918,3	K562	blood:
28	chr12:391396..394249-chr12:395350..397810,2	K562	blood:
29	chr12:423846..425522-chr12:432470..434859,2	K562	blood:
30	chr12:335174..337021-chr12:347324..348997,2	MCF-7	breast:
31	chr12:437485..439145-chr12:442839..444531,2	MCF-7	breast:
32	chr12:391396..393092-chr12:395064..396850,2	K562	blood:
33	chr12:238738..241077-chr12:328094..330048,2	K562	blood:
34	chr12:438334..440331-chr12:440530..443524,2	MCF-7	breast:
35	chr12:297943..299013-chr12:328724..329295,3	K562	blood:
36	chr12:437485..439145-chr12:442839..444531,2	MCF-7	breast:
37	chr12:329666..332151-chr12:332922..335452,2	MCF-7	breast:
38	chr12:297965..298734-chr12:308100..308686,2	MCF-7	breast:
39	chr12:402335..404067-chr12:405685..407593,2	K562	blood:
40	chr12:343024..345718-chr12:346456..348624,2	MCF-7	breast:
41	chr12:297943..299013-chr12:328724..329295,3	K562	blood:
42	chr12:312121..313775-chr12:317297..318932,2	K562	blood:
43	chr12:297600..300406-chr12:301338..304265,4	K562	blood:
44	chr12:399444..402323-chr12:403579..405598,2	K562	blood:
45	chr12:308043..310053-chr12:310352..312706,2	MCF-7	breast:
46	chr12:311759..314778-chr12:317325..320101,3	MCF-7	breast:
47	chr12:371632..373367-chr12:383696..385601,2	MCF-7	breast:
48	chr12:298095..299012-chr12:328485..329986,6	MCF-7	breast:
49	chr12:391396..394249-chr12:395350..397810,2	K562	blood:
50	chr12:418157..420807-chr12:497062..498857,2	MCF-7	breast:

(count:16 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IQSEC3-2	chr12:313184-313395	ENSG00000256577.1
2	lnc-KDM5A-2	chr12:366437-366465	ENSG00000255746.1
3	lnc-IQSEC3-2	chr12:313806-314228	NONHSAT025315
4	lnc-KDM5A-2	chr12:367087-367167	NONHSAT025324
5	lnc-KDM5A-2	chr12:365683-365806	NONHSAT025324
6	lnc-SLC6A13-1	chr12:321238-321276	NONHSAT025317
7	lnc-IQSEC3-2	chr12:312808-312905	ENSG00000256577.1
8	lnc-SLC6A13-1	chr12:322456-322883	NONHSAT025317
9	lnc-IQSEC3-1	chr12:302202-302346	ENSG00000255671.1
10	lnc-KDM5A-2	chr12:362608-362913	ENSG00000255746.1
11	lnc-IQSEC3-2	chr12:313033-313411	NONHSAT025315
12	lnc-KDM5A-1	chr12:383120-386289	ENSG00000261799.1
13	lnc-KDM5A-2	chr12:366437-366602	NONHSAT025324
14	lnc-IQSEC3-1	chr12:303127-303296	ENSG00000255671.1
15	lnc-IQSEC3-2	chr12:313806-314189	ENSG00000256577.1
16	lnc-KDM5A-2	chr12:365639-365806	ENSG00000255746.1

No data

Variant related genes	Relation type
ENSG00000256577	TF binding region
KDM5A	TF binding region
ENSG00000256540	TF binding region
ENSG00000255746	TF binding region
SLC6A13	TF binding region
SLC6A12	TF binding region
ENSG00000255671	TF binding region
ENSG00000261799	TF binding region
ENSG00000256577	CpG island
KDM5A	CpG island
ENSG00000256540	CpG island
ENSG00000255746	CpG island
SLC6A13	CpG island
SLC6A12	CpG island
ENSG00000255671	CpG island
ENSG00000261799	CpG island
ENSG00000111181	chromatin interactions
ENSG00000255671	chromatin interactions
ENSG00000073614	chromatin interactions
ENSG00000120645	chromatin interactions
ENSG00000255746	chromatin interactions
ENSG00000010379	chromatin interactions
ENSG00000256577	chromatin interactions
ENSG00000120647	chromatin interactions

Extended variants
information (count: 7608 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:7608 , 50 per page) page: 1 2 3 4 5 6 7 ... 153

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs80244282	chr12:296184-296185	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs575963453	chr12:296198-296199	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs78840976	chr12:296223-296224	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs538754981	chr12:296234-296235	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs543167850	chr12:296238-296239	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs561480193	chr12:296244-296245	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs558406	chr12:296245-296246	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs572023701	chr12:296249-296250	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs542219197	chr12:296250-296251	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs147499319	chr12:296251-296252	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs575978737	chr12:296255-296256	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs117741961	chr12:296274-296275	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs117124557	chr12:296292-296293	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs12304676	chr12:296293-296294	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs138400847	chr12:296298-296299	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs545639042	chr12:296304-296305	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs79516584	chr12:296310-296311	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs77869530	chr12:296318-296319	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs532078174	chr12:296355-296356	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs386759332	chr12:296373-296374	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs75905298	chr12:296374-296375	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs367648390	chr12:296396-296397	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs531699389	chr12:296402-296403	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs201098911	chr12:296419-296420	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs141879156	chr12:296424-296425	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs568600182	chr12:296474-296475	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs548458504	chr12:296475-296476	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs575607346	chr12:296477-296478	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs543331998	chr12:296478-296479	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs558394215	chr12:296482-296483	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs150618418	chr12:296483-296484	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs189025540	chr12:296484-296485	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs139709120	chr12:296493-296494	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs74057604	chr12:296510-296511	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
35	rs543128846	chr12:296519-296520	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs535941179	chr12:296527-296528	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs116941572	chr12:296543-296544	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs7967899	chr12:296549-296550	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs550512799	chr12:296558-296559	Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs565400439	chr12:296567-296568	Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs373962547	chr12:296569-296570	Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs181631032	chr12:296571-296572	Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs566257267	chr12:296576-296577	Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs535979280	chr12:296579-296580	Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs386759333	chr12:296580-296581	Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs569323910	chr12:296581-296582	Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs7967909	chr12:296582-296583	Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs558815764	chr12:296587-296588	Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs372559720	chr12:296588-296589	Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs190289665	chr12:296607-296608	Weak transcription Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Autism	22495309	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Glioblastoma multiforme	22291905	CNVD
Melanoma	20877625	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Pleomorphic liposarcoma	18784837	CNVD

Chromatin state (count:3668 , 50 per page) page: 1 2 3 4 5 6 7 ... 74

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:286200-298000	Weak transcription	Gastric	stomach
2	chr12:288400-297800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr12:288800-297200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr12:289200-297800	Weak transcription	Brain Anterior Caudate	brain
5	chr12:289600-298200	Weak transcription	HSMMtube	muscle
6	chr12:290000-297800	Weak transcription	Brain Inferior Temporal Lobe	brain
7	chr12:290000-297800	Weak transcription	HUVEC	blood vessel
8	chr12:290000-298000	Weak transcription	Esophagus	oesophagus
9	chr12:290200-297800	Weak transcription	Brain Hippocampus Middle	brain
10	chr12:291200-297600	Weak transcription	Pancreas	Pancrea
11	chr12:292000-297200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr12:292000-297600	Weak transcription	Right Ventricle	heart
13	chr12:292000-298200	Weak transcription	Placenta Amnion	Placenta Amnion
14	chr12:292600-298000	Weak transcription	NH-A	brain
15	chr12:292800-297800	Weak transcription	Left Ventricle	heart
16	chr12:294600-298000	Weak transcription	HSMM	muscle
17	chr12:294800-296400	Enhancers	Fetal Muscle Leg	muscle
18	chr12:295000-297800	Weak transcription	Primary hematopoietic stem cells	blood
19	chr12:295000-297800	Weak transcription	Adipose Nuclei	Adipose
20	chr12:295200-296200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
21	chr12:295200-297600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
22	chr12:295200-297600	Weak transcription	Spleen	Spleen
23	chr12:295200-298200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
24	chr12:295400-297600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
25	chr12:295400-298000	Weak transcription	Skeletal Muscle Female	skeletal muscle
26	chr12:295800-297800	Enhancers	Liver	Liver
27	chr12:296000-296200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr12:296000-296200	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
29	chr12:296200-296600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
30	chr12:296200-297800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
31	chr12:296400-296800	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
32	chr12:296600-296800	Bivalent Enhancer	K562	blood
33	chr12:296600-298000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
34	chr12:296800-297800	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
35	chr12:297200-297400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr12:297200-297800	Active TSS	HUES48 Cell Line	embryonic stem cell
37	chr12:297200-298400	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
38	chr12:297200-298600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
39	chr12:297400-297600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
40	chr12:297400-297800	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr12:297400-298400	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
42	chr12:297400-298400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
43	chr12:297600-297800	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
44	chr12:297600-297800	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr12:297600-297800	Enhancers	Right Ventricle	heart
46	chr12:297600-297800	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
47	chr12:297600-298000	Enhancers	Pancreas	Pancrea
48	chr12:297600-298200	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
49	chr12:297600-298400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
50	chr12:297600-298400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links